Acquisitions (Tables)

12 Months Ended

Dec. 31, 2011

Business Acquisition [Line Items]

Schedule Of Assets Acquired And Liabilities Assumed


Intangible assets—marketed products		$	951,200
Intangible assets—IPR&D			138,900
Goodwill			341,910
Deferred tax assets			413,816
Deferred tax liabilities			(426,861	)
Other assets/liabilities
Cash and cash equivalents			129,087
Marketable securities			116,363
Accounts receivable			9,136
Inventories			50,455
Prepaids and other current assets			60,671
Property, plant and equipment			11,672
Other assets			20,162
Accounts payable			(5,089	)
Accrued and other current liabilities			(87,898	)
Convertible senior notes			(303,060	)
Other liabilities			(27,906	)

Total other net liabilities			(26,407	)

Total consideration transferred		$	1,392,558

Calistoga Pharmaceuticals, Inc. [Member]

Business Acquisition [Line Items]

Fair Values Of The Assets Acquired And Liabilities Assumed


IPR&D		$	149,200
Goodwill			336,951
Other net liabilities assumed			(1,853	)

Total consideration transferred		$	484,298

Arresto Biosciences, Inc. [Member]

Business Acquisition [Line Items]

Fair Values Of The Assets Acquired And Liabilities Assumed


IPR&D		$	117,000
Goodwill			134,482
Deferred tax assets			17,417
Deferred tax liabilities			(41,705	)
Other net liabilities assumed			(125	)

Total consideration transferred		$	227,069

CGI Pharmaceuticals, Inc. [Member]

Business Acquisition [Line Items]

Fair Values Of The Assets Acquired And Liabilities Assumed


IPR&D		$	26,630
Goodwill			70,111
Deferred tax assets			12,656
Deferred tax liabilities			(6,313	)
Other net liabilities assumed			(984	)

Total consideration transferred		$	102,100